Marksans Pharma Posts ₹1.05 Billion Net Profit in Dec Quarter, Revenue Hits ₹6.82 Billion

Unknown Apr 02, 2026 750 Views

Marksans Pharma reported a consolidated net profit of ₹1.05 billion for the December 2024 quarter, showcasing significant growth. The company's revenue from operations surged to ₹6.82 billion, driven by strong performance across key markets, including the US and ANZ regions. Improved product...

Stay Ahead – Explore Now! Fueling the Future: India to Drive Half of Global Oil Demand Growth